Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic amyloidosis: recent advances.

M D Benson1, M R Wallace

  • 1Indiana University School of Medicine, Indianapolis, Indiana.

Advances in Nephrology From the Necker Hospital
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): Current Strategies and Guidelines.

Therapeutics and clinical risk management·2020
Same author

Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial.

European journal of neurology·2020
Same author

Associations of <i>P2RX7</i> Functional Diplotypes with Localized Aggressive Periodontitis.

JDR clinical and translational research·2019
Same author

Genetic polymorphisms and periodontal disease in populations of African descent: A review.

Journal of periodontal research·2017
Same author

Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.

Methods (San Diego, Calif.)·2017
Same author

The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.

Oncogene·2017

Hereditary amyloidoses, or familial amyloidotic polyneuropathy (FAP), cause nerve damage and often affect kidneys and heart. These organ issues, not neuropathy, typically determine patient survival length.

Area of Science:

  • Neurology
  • Cardiology
  • Nephrology

Background:

  • Hereditary amyloidoses, known as familial amyloidotic polyneuropathy (FAP), are characterized by peripheral neuropathy.
  • This neuropathy impacts sensory, motor, and autonomic nervous systems, leading to sensory loss, motor deficits, bowel issues, and orthostatic hypotension.

Purpose of the Study:

  • To elucidate the clinical manifestations and prognostic factors in hereditary amyloidoses.
  • To highlight the impact of systemic organ involvement on patient outcomes.

Main Methods:

  • Review of clinical presentations of hereditary amyloidosis patients.
  • Analysis of the correlation between neuropathy, organ involvement, and survival.

Main Results:

Related Experiment Videos

  • FAP syndromes frequently involve renal and cardiac systems alongside neuropathy.
  • Renal amyloidosis manifests as nephrotic syndrome progressing to azotemia.
  • Cardiac amyloidosis can present as congestive heart failure or arrhythmias.

    • Conclusions:

    • While neuropathy is a hallmark of FAP, renal and cardiac amyloidosis are critical determinants of survival.
    • Understanding systemic organ involvement is crucial for managing hereditary amyloidosis.